You are reading a study summary and it says "median survival: 14 months." It is easy to take that as a countdown. It isn't one, and a few plain definitions make the number much easier to read.

What the number means. The National Cancer Institute (NCI) defines median survival as the length of time, from diagnosis or the start of treatment, that half of the patients in a group are still alive. So if a study arm reports a median of 14 months, about half of the people in that arm were still alive after 14 months from the study's starting point, and about half were not. It does not mean everyone lived 14 months, and it does not say which half you would have been in.

Median is not the average. In everyday talk, "average" usually means the mean: add the values up and divide by how many there are. The median is the middle value. When survival times are uneven, a few people who live much longer or much shorter can pull a mean around. The median stays at the middle of the ordered times, which is one reason cancer papers often report it.

Where the clock starts matters. NCI's definitions allow either diagnosis or the start of treatment. In randomized trials, FDA guidance defines overall survival as the time from randomization until death from any cause. "Fourteen months from diagnosis" and "fourteen months from randomization" answer different questions, even though both use the word median.

Some people are still being followed. Trials don't wait until every participant has died to report. FDA guidance says that for patients alive at the data cut-off, observations are censored at the last date of documented survival. A median from an early look at a trial can change as more follow-up accumulates, so it is fair to ask how mature the data were.

A group number is not a personal forecast. NCI is direct about this: survival statistics are based on large groups, so they cannot predict exactly what will happen to one person. MedlinePlus makes the same point about health statistics in general.

Questions to bring to your care team:

  • Which group was this median measured in (stage, prior treatments, age range)?

  • When did the clock start: diagnosis, start of treatment, or randomization?

  • Is this overall survival, progression-free survival, or something else?

  • How long had people been followed when the median was reported?

  • How does this study population compare to my situation, and what does that leave uncertain for me?

Triangle Health's full explainer, with the NCI, SEER, FDA and MedlinePlus sources listed, is here: https://www.trianglehealth.com/blog/median-survival-meaning

Educational only, not medical advice. It does not replace your care team. Please discuss anything here with your clinician.